isoSolutions Marketing & Management Inc. offers a wide range of products for nuclear medicine applications, from a variety of reliable suppliers, providing a one-stop shopping service as well as technical support.
worldwide in 2017
on time in 2017
Posted by Kevin Yang ⎜ Nov 5, 2018
Radiolabeled somatostatin analog therapy has become an established treatment method for patients with well to moderately differentiated unresectable or metastatic neuroendocrine tumors (NETs). The most frequently used somatostatin analogs in clinical practice are octreotide and octreotate. …
Posted by David T. Drummond ⎜ Oct 29, 2018
A generous donor has given the B.C. Cancer Foundation $18.346 million, but insists on remaining anonymous.
“Today marks an important moment in cancer research and care in Canada with one of the largest donations ever made to bring new treatment solutions to patients,” said Sarah Roth, president and CEO of the B.C. Cancer Foundation. …
SNMMI 2019 Annual Meeting, June 22-25, 2019 in Anaheim, California. isoSolutions is pleased to inform you that we will attend the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
isoSolutions will be attending the United Pharmacy Partners (UPPI, LLC) 2018 Annual Meeting to be held in San Antonio, TX September 12 to 15, 2018.
The Chinese Society of Nuclear Medicine Annual Meeting will be held in Chengdu, Sichuan from 2018–07–12 to 2018–07–15. We hope to see you there and we can arrange a time and place to meet if you wish.